A drug target for erectile dysfunction to help improve fertility, sexual activity, and wellbeing: mendelian randomisation study
Benjamin Woolf, Skanda Rajasundaram, Héléne T Cronjé, James Yarmolinsky, Stephen Burgess, Dipender Gill · 2023
Read A drug target for erectile dysfunction to help improve fertility, sexual activity, and wellbeing: mendelian randomisation study by Benjamin Woolf, Skanda Rajasundaram, Héléne T Cronjé, James Yarmolinsky, Stephen Burgess, Dipender Gill (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10716676.txt.
Description
Benjamin Woolf and five co-authors ask what a common drug target does beyond its known use, in a 2023 study. The target, PDE5, is blocked by drugs for erectile dysfunction, and the team wanted its wider effects on fertility, sex life, and wellbeing.
Instead of a drug trial, they used genetics as a stand-in for blocking the target, drawing on blood pressure data from about 758,000 people and UK Biobank data for outcomes. Men with the genetic pattern linked to PDE5 blocking had fathered about 0.28 more children on average. No such link appeared in women. The team found no evidence of effects on number of partners, never having had sex, or self-rated wellbeing.
Catalog record
| CREATOR | Benjamin Woolf, Skanda Rajasundaram, Héléne T Cronjé, James Yarmolinsky, Stephen Burgess, Dipender Gill |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |